Askpot
← Company directory

Impella® Heart Pumps: SWOT analysis

Impella® Heart Pumps are the world's smallest heart pumps designed to provide hemodynamic support to patients with severe coronary artery disease or advanced heart failure. They utilize percutaneous catheter-based technology for minimally invasive treatment options.

Strengths

  • Abiomed's Impella® Heart Pumps are the smallest heart pumps available, allowing for less invasive procedures and quicker recovery times for patients.

  • The company has a strong commitment to research and development, ensuring continuous innovation in cardiac care technologies.

  • Abiomed provides comprehensive support for healthcare professionals, including on-site, on-call, and online clinical assistance.

  • The brand's tagline, 'Recovering Hearts. Saving Lives.®', effectively communicates its mission and resonates with both patients and healthcare providers.

  • The use of percutaneous catheter-based technology in Impella® Heart Pumps minimizes patient trauma and enhances recovery outcomes.

  • Abiomed has established a solid reputation in the healthcare industry, supported by over 300,000 patients treated with its heart pumps.

  • The company has successfully positioned itself as a leader in mechanical circulatory support, differentiating itself from competitors.

  • Recent financial growth, highlighted by a partnership with Johnson & Johnson, indicates strong market confidence and potential for expansion.

Weaknesses

Sign in to access Weaknesses

This content is available to registered users.

Sign in

Opportunities

Sign in to access Opportunities

This content is available to registered users.

Sign in

Threats

Sign in to access Threats

This content is available to registered users.

Sign in